Mechanisms and Therapeutic Potential of Targeting Mitophagy in Neurodegenerative Diseases.
Level 5 - mechanism / opinion, no new human data
Narrative review of biological mechanisms and therapeutic targets without original clinical data or systematic review methodology.
PubMed 42606666 · doi:10.1007/s12035-026-06104-3
What was done
This paper reviews the molecular mechanisms governing mitochondrial quality-control pathways, with a focus on mitophagy. It describes how impaired mitochondrial clearance contributes to neurodegenerative pathophysiology and summarizes potential therapeutic compounds targeting mitophagy.
What was found
The abstract reports no empirical measurements, quantitative statistics, or clinical effect sizes. It qualitatively describes that mitophagy selectively eliminates dysfunctional mitochondria to maintain cellular bioenergetics, and that failure of this pathway leads to proteostatic and metabolic collapse that aggravates neurodegeneration.
Why it matters
It outlines how mitochondrial quality-control failure contributes to neuronal vulnerability and catalogs molecular targets for potential drug development in neurodegenerative disorders.
Limits
The publication is a narrative review with no systematic search protocol, clinical trial data, or primary empirical measurements reported in the abstract. Translational efficacy and safety of targeting mitophagy in human patients are not established here.
Cited by
- supports Mitophagy is the cellular process of selectively degrading and recycling poorly functioning mitochondria.